0001447362-20-000201.txt : 20200903 0001447362-20-000201.hdr.sgml : 20200903 20200903160535 ACCESSION NUMBER: 0001447362-20-000201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200901 FILED AS OF DATE: 20200903 DATE AS OF CHANGE: 20200903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRADBURY DANIEL CENTRAL INDEX KEY: 0001236397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38984 FILM NUMBER: 201159326 MAIL ADDRESS: STREET 1: BIOBRIT, LLC STREET 2: 2223 AVENIDA DE LA PLAYA, SUITE 108 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC CENTRAL INDEX KEY: 0001447362 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770701774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 820 S FRIENDSWOOD DRIVE STREET 2: SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 BUSINESS PHONE: 866-788-9007 MAIL ADDRESS: STREET 1: 820 S FRIENDSWOOD DRIVE STREET 2: SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 4 1 wf-form4_159916351762732.xml FORM 4 X0306 4 2020-09-01 0 0001447362 CASTLE BIOSCIENCES INC CSTL 0001236397 BRADBURY DANIEL C/O CASTLE BIOSCIENCES, INC. 820 S. FRIENDSWOOD DRIVE, SUITE 201 FRIENDSWOOD TX 77546 1 0 0 0 Common Stock 2020-09-01 4 S 0 3750 45.88 D 844828 I By LLC Common Stock 2020-09-02 4 S 0 3650 45.43 D 841178 I By LLC Common Stock 2020-09-02 4 S 0 100 45.95 D 841078 I By LLC The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on March 13, 2020. This transaction was executed in multiple trades at prices ranging from $45.65 to $46.11, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Held by BioBrit, LLC (the "LLC"), of which the Reporting Person is the managing member and has voting and investment power over the shares. This transaction was executed in multiple trades at prices ranging from $44.93 to $45.76, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Greg Acosta, Attorney-in-fact 2020-09-03